{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:22:56Z","timestamp":1791894176342,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute of Aging","award":["P30 AG066509"],"award-info":[{"award-number":["P30 AG066509"]}]},{"DOI":"10.13039\/100007512","name":"Nancy and Buster Alvord Endowment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02931-1","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:13:21Z","timestamp":1756988001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"150","author":[{"given":"Jordan","family":"Ogg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Postupna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanelle","family":"Ariza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana M.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Jayadev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Dirk","family":"Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin S.","family":"Latimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"2931_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jalz.2015.07.490","volume":"12","author":"T Annus","year":"2016","unstructured":"Annus T, Wilson LR, Hong YT, Acosta-Cabronero J, Fryer TD, Cardenas-Blanco A et al (2016) The pattern of amyloid accumulation in the brains of adults with Down syndrome. Alzheimers Dement 12:538\u2013545. https:\/\/doi.org\/10.1016\/j.jalz.2015.07.490","journal-title":"Alzheimers Dement"},{"key":"2931_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.410230106","volume":"23","author":"TD Bird","year":"1988","unstructured":"Bird TD, Lampe TH, Nemens EJ, Miner GW, Sumi SM, Schellenberg GD (1988) Familial Alzheimer\u2019s disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol 23:25\u201331. https:\/\/doi.org\/10.1002\/ana.410230106","journal-title":"Ann Neurol"},{"key":"2931_CR3","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/ana.410400619","volume":"40","author":"TD Bird","year":"1996","unstructured":"Bird TD, Levy-Lahad E, Poorkaj P, Sharma V, Nemens E, Lahad A et al (1996) Wide range in age of onset for chromosome 1\u2013related familial Alzheimer\u2019s disease. Ann Neurol 40:932\u2013936. https:\/\/doi.org\/10.1002\/ana.410400619","journal-title":"Ann Neurol"},{"key":"2931_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"key":"2931_CR5","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25:5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"key":"2931_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S et al (2022) Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis 9:197\u2013210. https:\/\/doi.org\/10.14283\/jpad.2022.30","journal-title":"J Prev Alzheimers Dis"},{"key":"2931_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-011-0879-y","volume":"122","author":"YS Davidson","year":"2011","unstructured":"Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S et al (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer\u2019s disease, late onset Alzheimer\u2019s disease and Down\u2019s syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703\u2013713. https:\/\/doi.org\/10.1007\/s00401-011-0879-y","journal-title":"Acta Neuropathol"},{"key":"2931_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14:32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"key":"2931_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(18)30285-0","volume":"17","author":"J Fortea","year":"2018","unstructured":"Fortea J, Carmona-Iragui M, Benejam B, Fern\u00e1ndez S, Videla L, Barroeta I et al (2018) Plasma and CSF biomarkers for the diagnosis of Alzheimer\u2019s disease in adults with down syndrome: a cross-sectional study. Lancet Neurol 17:860\u2013869. https:\/\/doi.org\/10.1016\/S1474-4422(18)30285-0","journal-title":"Lancet Neurol"},{"key":"2931_CR10","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","volume":"395","author":"J Fortea","year":"2020","unstructured":"Fortea J, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, Barroeta I et al (2020) Clinical and biomarker changes of Alzheimer\u2019s disease in adults with down syndrome: a cross-sectional study. Lancet 395:1988\u20131997. https:\/\/doi.org\/10.1016\/S0140-6736(20)30689-9","journal-title":"Lancet"},{"key":"2931_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3233\/JAD-200492","volume":"77","author":"S Fung","year":"2020","unstructured":"Fung S, Smith CL, Prater KE, Case A, Green K, Osnis L et al (2020) Early-onset familial Alzheimer disease variant PSEN2 N141I heterozygosity is associated with altered microglia phenotype. J Alzheimers Dis 77:675\u2013688. https:\/\/doi.org\/10.3233\/JAD-200492","journal-title":"J Alzheimers Dis"},{"key":"2931_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.987212","volume":"16","author":"O Garc\u00eda","year":"2022","unstructured":"Garc\u00eda O, Flores-Aguilar L (2022) Astroglial and microglial pathology in down syndrome: focus on Alzheimer\u2019s disease. Front Cell Neurosci 16:987212. https:\/\/doi.org\/10.3389\/fncel.2022.987212","journal-title":"Front Cell Neurosci"},{"key":"2931_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.3810169","volume":"235","author":"D Goldgaber","year":"1987","unstructured":"Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer\u2019s disease. Science 235:877\u2013880. https:\/\/doi.org\/10.1126\/science.3810169","journal-title":"Science"},{"key":"2931_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051338","author":"A-C Granholm","year":"2024","unstructured":"Granholm A-C, Hamlett ED (2024) The role of tau pathology in Alzheimer\u2019s disease and down syndrome. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13051338","journal-title":"J Clin Med"},{"key":"2931_CR15","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26:5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"key":"2931_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jalz.2011.09.229","volume":"8","author":"BL Handen","year":"2012","unstructured":"Handen BL, Cohen AD, Channamalappa U, Bulova P, Cannon SA, Cohen WI et al (2012) Imaging brain amyloid in nondemented young adults with down syndrome using Pittsburgh compound B. Alzheimers Dement 8:496\u2013501. https:\/\/doi.org\/10.1016\/j.jalz.2011.09.229","journal-title":"Alzheimers Dement"},{"key":"2931_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217:459\u2013472. https:\/\/doi.org\/10.1083\/jcb.201709069","journal-title":"J Cell Biol"},{"key":"2931_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-v","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388. https:\/\/doi.org\/10.1016\/0165-6147(91)90609-v","journal-title":"Trends Pharmacol Sci"},{"key":"2931_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40478-017-0499-4","volume":"5","author":"E Head","year":"2017","unstructured":"Head E, Phelan MJ, Doran E, Kim RC, Poon WW, Schmitt FA et al (2017) Cerebrovascular pathology in down syndrome and Alzheimer disease. Acta Neuropathol Commun 5:93. https:\/\/doi.org\/10.1186\/s40478-017-0499-4","journal-title":"Acta Neuropathol Commun"},{"key":"2931_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","volume":"52","author":"PR Hof","year":"1995","unstructured":"Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH (1995) Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down\u2019s syndrome. Quantitative regional analysis and comparison with Alzheimer\u2019s disease. Arch Neurol 52:379\u2013391. https:\/\/doi.org\/10.1001\/archneur.1995.00540280065020","journal-title":"Arch Neurol"},{"key":"2931_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70071","volume":"21","author":"P Ivain","year":"2025","unstructured":"Ivain P, Baksh A, Saini F, Idris M, Tamayo-Elizalde M, Wells J et al (2025) Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer\u2019s disease in people with down syndrome: a horizon 21 European down syndrome Consortium study. Alzheimers Dement 21:e70071. https:\/\/doi.org\/10.1002\/alz.70071","journal-title":"Alzheimers Dement"},{"key":"2931_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/brain\/awq033","volume":"133","author":"S Jayadev","year":"2010","unstructured":"Jayadev S, Leverenz JB, Steinbart E, Stahl J, Klunk W, Yu C-E et al (2010) Alzheimer\u2019s disease phenotypes and genotypes associated with mutations in presenilin 2. Brain 133:1143\u20131154. https:\/\/doi.org\/10.1093\/brain\/awq033","journal-title":"Brain"},{"key":"2931_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1176\/ajp.105.2.102","volume":"105","author":"GA Jervis","year":"1948","unstructured":"Jervis GA (1948) Early senile dementia in mongoloid idiocy. Am J Psychiatry 105:102\u2013106. https:\/\/doi.org\/10.1176\/ajp.105.2.102","journal-title":"Am J Psychiatry"},{"key":"2931_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12213","volume":"17","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Jones DT, Greicius MD (2021) Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement 17:696\u2013701. https:\/\/doi.org\/10.1002\/alz.12213","journal-title":"Alzheimers Dement"},{"key":"2931_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/ana.25905","volume":"88","author":"PJ Lao","year":"2020","unstructured":"Lao PJ, Gutierrez J, Keator D, Rizvi B, Banerjee A, Igwe KC et al (2020) Alzheimer-related cerebrovascular disease in down syndrome. Ann Neurol 88:1165\u20131177. https:\/\/doi.org\/10.1002\/ana.25905","journal-title":"Ann Neurol"},{"key":"2931_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archneur.63.3.370","volume":"63","author":"JB Leverenz","year":"2006","unstructured":"Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E et al (2006) Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 63:370\u2013376. https:\/\/doi.org\/10.1001\/archneur.63.3.370","journal-title":"Arch Neurol"},{"key":"2931_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH et al (1995) Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus. Science 269:973\u2013977. https:\/\/doi.org\/10.1126\/science.7638622","journal-title":"Science"},{"key":"2931_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott IT, Head E (2019) Dementia in down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol 15:135\u2013147. https:\/\/doi.org\/10.1038\/s41582-018-0132-6","journal-title":"Nat Rev Neurol"},{"key":"2931_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0047-6374(88)90041-3","volume":"43","author":"DM Mann","year":"1988","unstructured":"Mann DM (1988) The pathological association between down syndrome and Alzheimer disease. Mech Ageing Dev 43:99\u2013136. https:\/\/doi.org\/10.1016\/0047-6374(88)90041-3","journal-title":"Mech Ageing Dev"},{"key":"2931_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12113","volume":"12","author":"AC Martini","year":"2020","unstructured":"Martini AC, Helman AM, McCarty KL, Lott IT, Doran E, Schmitt FA et al (2020) Distribution of microglial phenotypes as a function of age and Alzheimer\u2019s disease neuropathology in the brains of people with Down syndrome. Alzheimers Dement (N Y) 12:e12113. https:\/\/doi.org\/10.1002\/dad2.12113","journal-title":"Alzheimers Dement (N Y)"},{"key":"2931_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"issue":"1","key":"2931_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National institute on aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123(1):1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"2931_CR33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1046\/j.1471-4159.1994.62031062.x","volume":"62","author":"F Oyama","year":"1994","unstructured":"Oyama F, Cairns NJ, Shimada H, Oyama R, Titani K, Ihara Y (1994) Down\u2019s syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J Neurochem 62:1062\u20131066. https:\/\/doi.org\/10.1046\/j.1471-4159.1994.62031062.x","journal-title":"J Neurochem"},{"key":"2931_CR34","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/cells10030540","volume":"10","author":"P Preman","year":"2021","unstructured":"Preman P, Alfonso-Triguero M, Alberdi E, Verkhratsky A, Arranz AM (2021) Astrocytes in Alzheimer\u2019s disease: pathological significance and molecular pathways. Cells 10:540","journal-title":"Cells"},{"key":"2931_CR35","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE et al (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"key":"2931_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"2931_CR37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/hmg\/5.7.985","volume":"5","author":"R Sherrington","year":"1996","unstructured":"Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA et al (1996) Alzheimer\u2019s disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet 5:985\u2013988. https:\/\/doi.org\/10.1093\/hmg\/5.7.985","journal-title":"Hum Mol Genet"},{"key":"2931_CR38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 375:754\u2013760. https:\/\/doi.org\/10.1038\/375754a0","journal-title":"Nature"},{"key":"2931_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.870517","volume":"14","author":"M Shi","year":"2022","unstructured":"Shi M, Chu F, Zhu F, Zhu J (2022) Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on Aducanumab and Lecanemab. Front Aging Neurosci 14:870517. https:\/\/doi.org\/10.3389\/fnagi.2022.870517","journal-title":"Front Aging Neurosci"},{"key":"2931_CR40","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3233\/JAD-201248","volume":"79","author":"WJ Streit","year":"2021","unstructured":"Streit WJ, Khoshbouei H, Bechmann I (2021) The role of microglia in sporadic Alzheimer\u2019s disease. J Alzheimers Dis 79:961\u2013968. https:\/\/doi.org\/10.3233\/JAD-201248","journal-title":"J Alzheimers Dis"},{"key":"2931_CR41","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1073\/pnas.1618657114","volume":"114","author":"L Sun","year":"2017","unstructured":"Sun L, Zhou R, Yang G, Shi Y (2017) Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase. Proc Natl Acad Sci USA 114:E476\u2013E485. https:\/\/doi.org\/10.1073\/pnas.1618657114","journal-title":"Proc Natl Acad Sci USA"},{"key":"2931_CR42","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1471-4159.2004.02858.x","volume":"92","author":"ES Walker","year":"2005","unstructured":"Walker ES, Martinez M, Brunkan AL, Goate A (2005) Presenilin 2 familial Alzheimer\u2019s disease mutations result in partial loss of function and dramatic changes in Abeta 42\/40 ratios. J Neurochem 92:294\u2013301. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02858.x","journal-title":"J Neurochem"},{"key":"2931_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2019.01.008","volume":"77","author":"AM Wennberg","year":"2019","unstructured":"Wennberg AM, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Machulda MM et al (2019) The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals. Neurobiol Aging 77:26\u201336. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.01.008","journal-title":"Neurobiol Aging"},{"key":"2931_CR44","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1474-4422(24)00084-X","volume":"23","author":"JK Wisch","year":"2024","unstructured":"Wisch JK, McKay NS, Boerwinkle AH, Kennedy J, Flores S, Handen BL et al (2024) Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer\u2019s disease: a cross-sectional study. Lancet Neurol 23:500\u2013510. https:\/\/doi.org\/10.1016\/S1474-4422(24)00084-X","journal-title":"Lancet Neurol"},{"key":"2931_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70100","volume":"17","author":"X Yin","year":"2025","unstructured":"Yin X, Sun J, Wang X, Wu W, Chen Z, Zhang D et al (2025) Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer\u2019s disease and cognition in an autopsy-confirmed cohort from China. Alzheimers Dement (Amst) 17:e70100. https:\/\/doi.org\/10.1002\/dad2.70100","journal-title":"Alzheimers Dement (Amst)"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02931-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:13:22Z","timestamp":1756988002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02931-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2931"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02931-1","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent for research brain donation was obtained from the legal next of kin according to protocols approved by the University of Washington Institutional Review Board that conform to the provisions of the Declaration of Helsinki and preserve patient anonymity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"24"}}